3
Clinical Trials associated with Trafermin biosimilar (Translational Research Informatics Center)In-office Repair of Chronic Tympanic Membrane Perforations
The goal of this clinical trial is to compare the application of fibroblast growth factor 2 (FGF2) with normal saline for the healing of chronic tympanic membrane (TM) perforations. This is an extension of a prior study.
The main question it aims to answer is: Will modifications to our prior surgical trial provide higher success rates in obtaining complete closure of chronic tympanic membrane perforations? Twenty participants will be randomized in a controlled study to FGF2 or saline in a 3:1 ratio and the total tympanic membrane closure compared.
Regenerative Therapy for Soft Tissue Defects of the External Auditory Meatus with NPC-18
Start Date01 May 2023 |
Sponsor / Collaborator- |
A Phase III study on the regenerative treatment of tympanic membrane with NPC-18 and FBG-18-multicenter,investigator initiated clinical trial. - A Phase III study on the regenerative treatment of tympanic membrane with NPC-18 and FBG-18-multicenter,investigator initiated clinical trial.
Start Date26 Mar 2015 |
Sponsor / Collaborator- |
100 Clinical Results associated with Trafermin biosimilar (Translational Research Informatics Center)
100 Translational Medicine associated with Trafermin biosimilar (Translational Research Informatics Center)
100 Patents (Medical) associated with Trafermin biosimilar (Translational Research Informatics Center)
100 Deals associated with Trafermin biosimilar (Translational Research Informatics Center)